Immuneering Corp. (IMRX)
5.21
-0.01
(-0.19%)
USD |
NASDAQ |
May 11, 16:00
5.21
0.00 (0.00%)
After-Hours: 18:51
Immuneering EPS Diluted (Quarterly) : -0.1793 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| X4 Pharmaceuticals, Inc. | -0.1603 |
| vTv Therapeutics, Inc. | -0.5752 |
| Design Therapeutics, Inc. | -0.2871 |
| Tango Therapeutics, Inc. | -0.2945 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.58M |
| Total Expenses (Quarterly) | 11.58M |
| Enterprise Value | 168.71M |
| Earnings Yield | -26.51% |
| Normalized Earnings Yield | -26.51 |